Applied Microbiology and Biotechnology

, Volume 102, Issue 9, pp 4131–4142 | Cite as

A 12-residue epitope displayed on phage T7 reacts strongly with antibodies against foot-and-mouth disease virus

  • Chuan Loo Wong
  • Chean Yeah Yong
  • Azira Muhamad
  • Amir Syahir
  • Abdul Rahman Omar
  • Chin Chin Sieo
  • Wen Siang Tan
Applied genetics and molecular biotechnology

Abstract

Foot-and-mouth disease (FMD) is a major threat to the livestock industry worldwide. Despite constant surveillance and effective vaccination, the perpetual mutations of the foot-and-mouth disease virus (FMDV) pose a huge challenge to FMD diagnosis. The immunodominant region of the FMDV VP1 protein (residues 131–170) displayed on phage T7 has been used to detect anti-FMDV in bovine sera. In the present study, the functional epitope was further delineated using amino acid sequence alignment, homology modelling and phage display. Two highly conserved regions (VP1145–152 and VP1159–170) were identified among different FMDV serotypes. The coding regions of these two epitopes were fused separately to the T7 genome and displayed on the phage particles. Interestingly, chimeric phage displaying the VP1159–170 epitope demonstrated a higher antigenicity than that displaying the VP1131–170 epitope. By contrast, phage T7 displaying the VP1145–152 epitope did not react significantly with the anti-FMDV antibodies in vaccinated bovine sera. This study has successfully identified a smaller functional epitope, VP1159–170, located at the C-terminal end of the structural VP1 protein. The phage T7 displaying this shorter epitope is a promising diagnostic reagent to detect anti-FMDV antibodies in vaccinated animals.

Keywords

Diagnostic reagent ELISA Foot-and-mouth disease Phage display VP1 epitope 

Notes

Acknowledgements

The authors thank Dr. Baljit Singh (Universiti Putra Malaysia) for technical assistance in collection of bovine sera and J.Y. Chia for technical assistance in homology modelling.

Compliance with ethical standards

Conflict of interest

Wong CL declares that she has no conflict of interest. Yong CY declares that he has no conflict of interest. Muhamad A declares that she has no conflict of interest. Syahir A declares that he has no conflict of interest. Omar AR declares that he has no conflict of interest. Sieo CC declares that she has no conflict of interest. Tan WS declares that he has no conflict of interest.

Ethical statement

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

253_2018_8921_MOESM1_ESM.pdf (529 kb)
ESM 1 (PDF 528 kb)

References

  1. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F (1990) The structure of foot-and-mouth disease virus: implications for its physical and biological properties. Vet Microb 23:21–34.  https://doi.org/10.1016/0378-1135(90)90134-H CrossRefGoogle Scholar
  2. Adams MH (1959) Assay of phages by the agar layer method. In: Adams MH (ed) Bacteriophages, 1st edn. Interscience Publishers, New York, pp 450–451Google Scholar
  3. Alexandersen S, Mowat N (2005) Foot-and-mouth disease: host-range and pathogenesis. Curr Top Microbiol Immunol 288:9–42PubMedGoogle Scholar
  4. Alexandersen S, Zhang Z, Donaldson AI, Garland AJM (2003) The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 129:1–36.  https://doi.org/10.1016/S0021-9975(03)00041-0 CrossRefPubMedGoogle Scholar
  5. Baxt B, Becker Y (1990) The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73–80CrossRefPubMedGoogle Scholar
  6. Biasani M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:252–258.  https://doi.org/10.1093/nar/gku340 CrossRefGoogle Scholar
  7. Carrillo C (2012) Foot-and-mouth disease virus genome. In: Garcia ML, Romanowski V (eds) Viral genomes-molecular structure, diversity, gene expression mechanisms and host-virus interactions, 1st edn. InTech, Rijeka, pp 53–68Google Scholar
  8. Clavijo A, Wright P, Kitching P (2004) Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet J 167:9–22.  https://doi.org/10.1016/S1090-0233(03)00087-X CrossRefPubMedGoogle Scholar
  9. Colling A, Morrissy C, Barr J, Meehan G, Wright L, Goff W, Gleeson LJ, van der Heide B, Riddell S, Yu M, Eagles D, Lunt R, Khounsy S, Than Long NG, Phong Vu P, Than Phuong N, Tung N, Linchongsubongkoch W, Hammond J, Johnson M, Johnson WO, Unger H, Daniels P, Crowther JR (2014) Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth disease. Aust Vet J 92:192–199.  https://doi.org/10.1111/avj.12190 CrossRefPubMedGoogle Scholar
  10. Crowther JR, Farias S, Carpenter WC, Samuel AR (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of a single and quintuple monoclonal antibody escape mutants. J Gen Virol 74:1547–1553.  https://doi.org/10.1099/0022-1317-74-8-1547 CrossRefPubMedGoogle Scholar
  11. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D (1996) Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4:135–145.  https://doi.org/10.1016/S0969-2126(96)00017-2 CrossRefPubMedGoogle Scholar
  12. de Jong WW, Zweers A, Cohen LH (1978) Influence of single amino acid substitutions on electrophoretic mobility of sodium dodecyl sulfate-protein complexes. Biochem Biophys Res Commun 82:532–539.  https://doi.org/10.1016/0006-291x(78)90907-5 CrossRefPubMedGoogle Scholar
  13. Eshaghi M, Tan WS, Ong ST, Yusoff K (2005) Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells. J Clin Microbiol 43:3172–4177.  https://doi.org/10.1128/JCM.43.7.3172-3177.2005 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Forss S, Strebel K, Beck E, Schaller H (1984) Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12:6587–6601.  https://doi.org/10.1093/nar/12.16.6587 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Fowler VL, Bashiruddin JB, Maree FF, Mutowembwa P, Bankowski B, Gibson D, Cox S, Knowles N, Barnett PV (2011) Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 29:8405–8411.  https://doi.org/10.1016/j.vaccine.2011.08.035 CrossRefPubMedGoogle Scholar
  16. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis 18:2714–2723.  https://doi.org/10.1002/elps.1150181505 CrossRefPubMedGoogle Scholar
  17. Hamblin C, Barnett IT, Hedger RS (1986) A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and mouth disease virus. I. Development and method of ELISA. J Immunol Methods 93:115–121.  https://doi.org/10.1016/0022-1759(86)90441-2 CrossRefPubMedGoogle Scholar
  18. Jamal SM, Belsham GJ (2013) Foot-and-mouth disease: past, present and future. Vet Res 44:116–129.  https://doi.org/10.1186/1297-9716-44-116 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Kho CL, Tan WS, Yusoff K (2002) Cloning and expression of the phosphoprotein gene of Newcastle disease virus in Escherichia coli. J Biochem Mol Biol Biophys 6:117–121.  https://doi.org/10.1080/10258140290027252 CrossRefPubMedGoogle Scholar
  20. Kitson JDA, McCahon D, Belsham GJ (1990) Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34.  https://doi.org/10.1016/0042-6822(90)90269-W CrossRefPubMedGoogle Scholar
  21. Klein J (2009) Understanding the molecular epidemiology of foot-and-mouth-disease virus. Infect Genet Evol 9:153–161.  https://doi.org/10.1016/j.meegid.2008.11.005 CrossRefPubMedGoogle Scholar
  22. Knight-Jones TJD, Rushton J (2013) The economic impacts of foot-and-mouth disease—what are they, how big are they and where do they occur? Prev Vet Med 112:161–173.  https://doi.org/10.1016/j.prevetmed.2013.07.013 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Krezel AM, Wagner G, Seymour-Ulmer J, Lazarus RA (1994) Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. Science 264:1944–1947.  https://doi.org/10.1126/science.8009227 CrossRefPubMedGoogle Scholar
  24. Lazarus RA, McDowell RS (1993) Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIa. Curr Opin Struct Biol 4:438–445.  https://doi.org/10.1016/0958-1669(93)90009-L Google Scholar
  25. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, Rowlands D, Stuart D, Fry E (1993) Structure of a major antigenic site on foot-and-mouth disease virus. Nature 362:566–588.  https://doi.org/10.1038/362566a0 CrossRefPubMedGoogle Scholar
  26. Ma LN, Zhang J, Chen HT, Zhou JH, Ding YZ, Liu YS (2011) An overview on ELISA techniques for FMD. Virol J 8:419–427.  https://doi.org/10.1186/1743-422X-8-419 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Mackay DK, Bulut AN, Rendle T, Davidson F, Ferris NP (2001) A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods 97:33–48.  https://doi.org/10.1016/S0166-0934(01)00333-0 CrossRefPubMedGoogle Scholar
  28. Netter HJ, Macnaughton TB, Woo WP, Tindle R, Gowans EJ (2001) Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes. J Virol 75:2130–2141.  https://doi.org/10.1128/JVI.75.5.2130-2141.2001 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Oem JK, Lee KN, Cho IS, Kye SJ, Park JY, Park JH, Kim YJ, Joo YS, Song HJ (2005) Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea. J Vet Sci 6:117–124PubMedGoogle Scholar
  30. OIE (2011) Foot and mouth disease. Terrestrial Animal Health Code. http://www.oie.int/eng/A_FMD2012/docs/en_chapitre_1.8.5.pdf. Accessed 15 Aug 2017
  31. OIE (2017) Foot and mouth disease (Infection with foot and mouth disease virus). Terrestrial Animal Manual. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.08_FMD.pdf. Accessed 15 Aug 2017
  32. OIE, FAO (2012) The Global Foot and Mouth Disease Control Strategy—strengthening animal health systems through improved control of major diseases. http://www.oie.int/doc/ged/D11886.PDF. Accessed 2 Feb 2018
  33. Panayotatos N, Radziejewska E, Acheson A, Pearsall D, Thadani A, Wong V (1993) Exchange of a single amino acid interconverts the specific activity and gel mobility of human and rat ciliary neurotrophic factors. J Biol Chem 268:19000–19003PubMedGoogle Scholar
  34. Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 18:3217–3226.  https://doi.org/10.1093/hmg/ddp260 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Ptaff E, Thiel HJ, Strohmaier K, Schaller H (1988) Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Gen Virol 62:2033–2020Google Scholar
  36. Rae BP, Elliott RM (1986) Characterization of the mutations responsible for the electrophoretic mobility differences in the NS proteins of vesicular stomatitis virus New Jersey complementation group E mutants. J Gen Virol 67:2635–2643.  https://doi.org/10.1099/0022-1317-67-12-2635 CrossRefPubMedGoogle Scholar
  37. Rémond M, Da Costa B, Riffault S, Parida S, Breard E, Lebreton F, Zientara S, Delmas B (2009) Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site. Vaccine 27:93–98.  https://doi.org/10.1016/j.vaccine.2008.10.036 CrossRefPubMedGoogle Scholar
  38. Robinson TP, Thornton PK, Franceschini G, Kruska RL, Chiozza F, Notenbaert A, Cecchi G, Herrero M, Epprecht M, Fritz S, You L, Conchedda G, See L (2011) Global livestock production systems. Rome, FAO of the United Nations and ILRI, p 152. http://www.fao.org/docrep/014/i2414e/i2414e.pdf. Accessed 19 Aug 2017
  39. Rosenberg AH, Griffin K, Washington MT, Patel SS, Studier FW (1996) Selection, identification, and genetic analysis of random mutants in the cloned primase/helicase gene of bacteriophage T7. J Biol Chem 271:26819–26824.  https://doi.org/10.1074/jbc.271.43.26819 CrossRefPubMedGoogle Scholar
  40. Shi Y, Mowery RA, Ashley J, Hentz M, Ramirez AJ, Bilgicer B, Slunt-Brown H, Borchelt DR, Shaw BF (2012) Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding. Protein Sci 21:1197–1209.  https://doi.org/10.1002/pro.2107 CrossRefPubMedPubMedCentralGoogle Scholar
  41. Smith MT, Bennett AM, Grubman MJ, Bundy BC (2014) Foot-and-mouth disease: technical and political challenges to eradication. Vaccine 32:3902–3908.  https://doi.org/10.1016/j.vaccine.2014.04.038 CrossRefPubMedGoogle Scholar
  42. Smith GW, Hightower LE (1981) Identification of the P proteins and other disulfide-linked and phosphorylated proteins of Newcastle disease virus. J Virol 37:256–267PubMedPubMedCentralGoogle Scholar
  43. Sutmoller P, Barteling SS, Olascoaga RC, Sumption KJ (2003) Control and eradication of foot-and-mouth disease. Virus Res 91:101–144.  https://doi.org/10.1016/s0168-1702(02)00262-9 CrossRefPubMedGoogle Scholar
  44. Tan GH, Yusoff K, Seow HF, Tan WS (2005) Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. J Med Virol 77:475–480.  https://doi.org/10.1002/jmv.20479 CrossRefPubMedGoogle Scholar
  45. Uttenthal A, Parida S, Rasmussen TB, Paton DJ, Haas B, Dundon WG (2010) Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev Vaccines 9:73–87.  https://doi.org/10.1586/erv.09.130 CrossRefPubMedGoogle Scholar
  46. Wattanaphansak S, Asawakarn T, Gebhart CJ, Deen J (2008) Development and validation of an enzyme-linked immunosorbent assay for the diagnosis of porcine proliferative enteropathy. J Vet Diagn Investig 20:170–177.  https://doi.org/10.1177/104063870802000205 CrossRefGoogle Scholar
  47. Wong CL, Sieo CC, Tan WS (2013) Display of the VP1 epitope of foot-and-mouth disease virus on bacteriophage T7 and its application in diagnosis. J Virol Methods 193:611–619.  https://doi.org/10.1016/j.jviromet.2013.07.053 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Chuan Loo Wong
    • 1
  • Chean Yeah Yong
    • 1
    • 2
  • Azira Muhamad
    • 3
  • Amir Syahir
    • 4
  • Abdul Rahman Omar
    • 2
  • Chin Chin Sieo
    • 1
    • 2
  • Wen Siang Tan
    • 1
    • 2
  1. 1.Department of Microbiology, Faculty of Biotechnology and Biomolecular SciencesUniversiti Putra MalaysiaSerdangMalaysia
  2. 2.Laboratory of Vaccines and Immunotherapeutics, Institute of BiosciencesUniversiti Putra MalaysiaSerdangMalaysia
  3. 3.Malaysia Genome Institute, National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and InnovationKajangMalaysia
  4. 4.Department of Biochemistry, Faculty of Biotechnology and Biomolecular SciencesUniversiti Putra MalaysiaSerdangMalaysia

Personalised recommendations